277 related articles for article (PubMed ID: 16183476)
1. Radiochemotherapy in the management of pancreatic cancer--part I: neoadjuvant treatment.
Mornex F; Girard N; Delpero JR; Partensky C
Semin Radiat Oncol; 2005 Oct; 15(4):226-34. PubMed ID: 16183476
[TBL] [Abstract][Full Text] [Related]
2. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.
Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Roy P; Scoazec JY
Am J Clin Oncol; 2008 Dec; 31(6):545-52. PubMed ID: 19060585
[TBL] [Abstract][Full Text] [Related]
3. Adenocarcinoma of the pancreas: the rationale for neoadjuvant therapy.
Sperti C; Pasquali C; Pastorelli D; Ferronato A; Decet G; Pedrazzoli S
Acta Biomed; 2003; 74 Suppl 2():91-5. PubMed ID: 15055044
[TBL] [Abstract][Full Text] [Related]
4. Is there a role for chemoradiotherapy in the treatment of pancreatic carcinoma?
Pasetto LM; Jirillo A; Stefani M; Monfardini S
Anticancer Res; 2003; 23(3C):2805-13. PubMed ID: 12926117
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant therapy in pancreatic cancer.
Quiros RM; Brown KM; Hoffman JP
Cancer Invest; 2007 Jun; 25(4):267-73. PubMed ID: 17612937
[TBL] [Abstract][Full Text] [Related]
6. Rapid-fractionation pre-operative chemoradiation for malignant periampullary neoplasms.
Evans OB; Abbruzzese JL; Cleary KR; Lee JE; Buchholz DJ; Rich TA
J R Coll Surg Edinb; 1995 Oct; 40(5):319-23. PubMed ID: 8523311
[TBL] [Abstract][Full Text] [Related]
7. Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer.
White RR; Xie HB; Gottfried MR; Czito BG; Hurwitz HI; Morse MA; Blobe GC; Paulson EK; Baillie J; Branch MS; Jowell PS; Clary BM; Pappas TN; Tyler DS
Ann Surg Oncol; 2005 Mar; 12(3):214-21. PubMed ID: 15827813
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial.
Mornex F; Girard N; Scoazec JY; Bossard N; Ychou M; Smith D; Seitz JF; Valette PJ; Roy P; Rouanet P; Ducreux M; Partensky C
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1471-8. PubMed ID: 16793214
[TBL] [Abstract][Full Text] [Related]
9. Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis.
Showalter TN; Rao AS; Rani Anne P; Rosato FE; Rosato EL; Andrel J; Hyslop T; Xu X; Berger AC
Ann Surg Oncol; 2009 Aug; 16(8):2116-22. PubMed ID: 19437078
[TBL] [Abstract][Full Text] [Related]
10. Multimodality management of localized pancreatic cancer.
Wayne JD; Wolff RA; Pisters PW; Evans DB
Cancer J; 2001; 7 Suppl 1():S35-46. PubMed ID: 11504284
[TBL] [Abstract][Full Text] [Related]
11. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume.
Bilimoria KY; Bentrem DJ; Ko CY; Tomlinson JS; Stewart AK; Winchester DP; Talamonti MS
Cancer; 2007 Sep; 110(6):1227-34. PubMed ID: 17654662
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.
Massucco P; Capussotti L; Magnino A; Sperti E; Gatti M; Muratore A; Sgotto E; Gabriele P; Aglietta M
Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382
[TBL] [Abstract][Full Text] [Related]
13. Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.
Brown KM; Siripurapu V; Davidson M; Cohen SJ; Konski A; Watson JC; Li T; Ciocca V; Cooper H; Hoffman JP
Am J Surg; 2008 Mar; 195(3):318-21. PubMed ID: 18308038
[TBL] [Abstract][Full Text] [Related]
14. Effect of neoadjuvant therapy on local recurrence after resection of pancreatic adenocarcinoma.
Greer SE; Pipas JM; Sutton JE; Zaki BI; Tsapakos M; Colacchio TA; Gibson JJ; Wiener DC; Ripple GH; Barth RJ
J Am Coll Surg; 2008 Mar; 206(3):451-7. PubMed ID: 18308215
[TBL] [Abstract][Full Text] [Related]
15. [Adjuvant and neoadjuvant treatment for pancreatic adenocarcinoma in 2006].
Deberne M; Huguet F; Le Scodan R; Hammel P; Andre T
Bull Cancer; 2007 Jan; 94(1):72-80. PubMed ID: 17237007
[TBL] [Abstract][Full Text] [Related]
16. Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy.
Golcher H; Brunner T; Grabenbauer G; Merkel S; Papadopoulos T; Hohenberger W; Meyer T
Eur J Surg Oncol; 2008 Jul; 34(7):756-64. PubMed ID: 18191528
[TBL] [Abstract][Full Text] [Related]
17. Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas.
White R; Lee C; Anscher M; Gottfried M; Wolff R; Keogan M; Pappas T; Hurwitz H; Tyler D
Ann Surg Oncol; 1999; 6(1):38-45. PubMed ID: 10030414
[TBL] [Abstract][Full Text] [Related]
18. [Pancreatic carcinoma. Optimizing therapy by adjuvant and neoadjuvant therapy?].
Maurer CA; Zgraggen K; Büchler MW
Zentralbl Chir; 1999; 124(5):401-7. PubMed ID: 10420525
[TBL] [Abstract][Full Text] [Related]
19. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
[TBL] [Abstract][Full Text] [Related]
20. Therapy of locally advanced pancreatic adenocarcinoma: unresectable and borderline patients.
Kircher SM; Krantz SB; Nimeiri HS; Mulcahy MF; Munshi HG; Benson AB
Expert Rev Anticancer Ther; 2011 Oct; 11(10):1555-65. PubMed ID: 21999129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]